STOCK TITAN

SHERWIN WILLIAMS CO (SHW) SEC Filings, Feb 17-18, 2026

SHW NYSE

The Sherwin-Williams Company filings document operating results, governance actions, and capital-structure matters for an Ohio paint and coatings issuer with common stock listed on the New York Stock Exchange under SHW. Recent Form 8-K reports furnish quarterly and annual financial results, including net sales, earnings measures, segment performance, guidance, and Valspar acquisition-related amortization.

Proxy and annual-meeting filings cover director elections, advisory executive-compensation votes, auditor ratification, shareholder voting results, and pay-versus-performance disclosures. Other 8-K filings record material definitive agreements, amendments to credit facilities, borrowing and letter-of-credit commitments, covenants, events of default, and related direct financial obligations.

Rhea-AI Summary

Sherwin-Williams senior vice president and chief legal officer Mary L. Garceau reported equity compensation activity in company common stock. She acquired 9,000 shares at a stated price of $0.0000 through a performance-based restricted stock unit award that vested based on 2023–2025 performance conditions. On the same date, 3,618 shares at $368.5900 per share were withheld by the company to cover her tax obligations from this vesting, meaning these were not open-market sales. Following these transactions, she directly held 35,357 shares of common stock and indirectly held 901.97 shares through The Sherwin-Williams Company 401(k) Plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.23%
Tags
insider
-
Rhea-AI Summary

The Sherwin-Williams Company executive Colin M. Davie reported equity compensation activity involving company common stock. He acquired 3,300 shares on a grant or award basis at $0.0000 per share, tied to a performance-based restricted stock unit (PRSU) award that vested for the 2023–2025 performance period.

To cover related tax withholding obligations upon this PRSU vesting, 1,346 shares were disposed of at $368.5900 per share through a tax-withholding transaction, rather than an open-market sale. After these transactions, he directly owned 7,319 common shares, and an additional 563.36 shares were held indirectly through The Sherwin-Williams Company 401(k) Plan as of the trustee’s 2/13/2026 statement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.23%
Tags
insider
-
Rhea-AI Summary

Sherwin-Williams Company senior vice president and CHRO Marlena K. Boyce reported equity compensation activity in company stock. On February 17, 2026, she acquired 1,338 shares of common stock at $0.00 per share from a performance-based restricted stock unit (PRSU) award granted on February 14, 2023 for the 2023–2025 performance period. To cover tax withholding on this vesting, 411 shares were mandatorily surrendered back to the company at $368.59 per share, a tax-withholding disposition rather than an open-market sale. After these transactions, she directly owned 1,285 shares of Sherwin-Williams common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.23%
Tags
insider
Rhea-AI Summary

Sherwin-Williams executive Justin T. Binns reported equity compensation activity involving common stock. He acquired 9,900 shares through the vesting and payout of a performance-based restricted stock unit (PRSU) award covering the 2023–2025 performance period, granted under the company’s equity and performance incentive plan.

To cover tax withholding on this vesting, 4,416 shares were mandatorily withheld by the company at a price of $368.59 per share, a non-open-market, tax-withholding disposition. After these transactions, he directly holds 21,937 common shares and has an additional 5,922.35 shares attributable to his participation in The Sherwin-Williams Company 401(k) Plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.23%
Tags
insider
-
Rhea-AI Summary

Director Thomas Williams reported an acquisition of 558 shares of Sherwin-Williams common stock on a grant of restricted stock units under the 2025 Equity and Incentive Compensation Plan. Each RSU equals one share of common stock and vests in three annual installments starting February 16, 2027.

After this award, Williams holds 2,371 shares of Sherwin-Williams common stock directly and 1,053.14 deferred stock units indirectly through the 2005 Director Deferred Fee Plan, which also accumulates units via a dividend reinvestment feature.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.59%
Tags
insider
-
Rhea-AI Summary

Sherwin-Williams director Aaron Powell reported an equity award tied to 558 shares of Common Stock on February 17, 2026. The filing classifies this as an acquisition granted at a price of $0.00 per share under The Sherwin-Williams Company 2025 Equity and Incentive Compensation Plan.

The award is in the form of restricted stock units, each representing the right to receive one share of Common Stock. These RSUs vest annually in three substantially equal installments starting on February 16, 2027. After this grant, Powell beneficially owns 3,587 shares in total, consisting of 1,100 RSUs and 2,487 shares of Common Stock held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.59%
Tags
insider
Rhea-AI Summary

The Sherwin-Williams Company director Matthew Thornton III received an equity award in the form of restricted stock units that convert into common stock. On February 17, 2026, he acquired 558 shares of common stock at a price of $0 per share as part of this grant.

The award was made under The Sherwin-Williams Company 2025 Equity and Incentive Compensation Plan. The restricted stock units vest in three substantially equal annual installments starting on February 16, 2027. Following this transaction, he beneficially owned 12,854 common shares, including 1,100 RSUs and 11,754 shares of common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.59%
Tags
insider
-
Rhea-AI Summary

THAMAN MICHAEL H reported acquisition or exercise transactions in this Form 4 filing.

Sherwin-Williams director Michael H. Thaman reported an award of 558 restricted stock units, each representing one share of Common Stock, granted at $0 under the 2025 Equity and Incentive Compensation Plan. The RSUs vest in three annual installments starting on February 16, 2027. After this grant, he beneficially owns 8,111 shares and RSUs directly and 5,480.97 deferred stock units indirectly through the 2005 Director Deferred Fee Plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.59%
Tags
insider
-
Rhea-AI Summary

STEWART MARTA R reported acquisition or exercise transactions in a Form 4 filing for SHW. The filing lists transactions totaling 558 shares. Following the reported transactions, holdings were 3,484 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.59%
Tags
insider
Rhea-AI Summary

Gamgort Robert James reported acquisition or exercise transactions in this Form 4 filing.

Sherwin-Williams director Robert James Gamgort reported receiving a grant of 558 restricted stock units (RSUs) of Common Stock on February 17, 2026 at a reported price of $0 per share under the 2025 Equity and Incentive Compensation Plan. Each RSU represents one share of Sherwin-Williams common stock and will vest in three substantially equal annual installments starting on February 16, 2027. After this grant, Gamgort beneficially owns 1,075 RSUs directly, and separately holds 380.04 deferred stock units indirectly through the 2005 Director Deferred Fee Plan, including units accumulated via dividend reinvestment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.59%
Tags
insider

FAQ

How many SHERWIN WILLIAMS CO (SHW) SEC filings are available on StockTitan?

StockTitan tracks 123 SEC filings for SHERWIN WILLIAMS CO (SHW), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for SHERWIN WILLIAMS CO (SHW)?

The most recent SEC filing for SHERWIN WILLIAMS CO (SHW) was filed on November 6, 2026.